“Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
, “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
, “Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.”, Biol Blood Marrow Transplant, vol. 24, no. 6, pp. 1274-1280, 2018.
, “Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
, “Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy.”, Epilepsy Behav, vol. 84, pp. 10-14, 2018.
, “CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.”, Lancet Infect Dis, vol. 18, no. 10, pp. 1097-1107, 2018.
, “Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.
, “A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations.”, Dev Med Child Neurol, vol. 60, no. 10, pp. 976-986, 2018.
, “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
, “Comparison of Glycated Hemoglobin Results Based on At-Home and In-Lab Dried Blood Spot Sampling to Routine Venous Blood Sampling In-Lab in Adult Patients With Type 1 or Type 2 Diabetes.”, Can J Diabetes, vol. 42, no. 4, pp. 426-432.e1, 2018.
, “Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.”, JAMA Ophthalmol, vol. 136, no. 4, pp. 337-345, 2018.
, “CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.”, Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
, “CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S27-S32, 2018.
, “Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.”, Br J Ophthalmol, vol. 102, no. 4, pp. 465-472, 2018.
, “The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.”, JNCI Cancer Spectr, vol. 2, no. 3, p. pky021, 2018.
, “Data sharing platforms for de-identified data from human clinical trials.”, Clin Trials, vol. 15, no. 4, pp. 413-423, 2018.
, “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
, “Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study”, Blood, vol. 132, no. Supplement 1, p. 4370, 2018.
, “DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.”, PLoS One, vol. 13, no. 11, p. e0206837, 2018.
, “Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.”, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
, “Early-life gut microbiome and egg allergy.”, Allergy, vol. 73, no. 7, pp. 1515-1524, 2018.
, “Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.”, Biol Blood Marrow Transplant, vol. 24, no. 10, pp. 2145-2151, 2018.
, “Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.”, JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
, “Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy.”, J Allergy Clin Immunol, vol. 142, no. 1, pp. 149-158.e8, 2018.
,